DexCom, Inc.

DXCM · Healthcare · · USD

87.90 USD

0.00 (-2.02%)

● Updated 2026-09-07 19:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 75

Trend & RS 95

Momentum 80

Fundamental 89

Macro 64

Liquidity 40

Component	Score	Weight
Technical	75.0	20%
Trend & RS	95.2	30%
Momentum	79.9	15%
Fundamental	88.9	10%
Macro	64.4	20%
Liquidity	39.6	5%

Trade Setup

Entry	87.90
Stop Loss	82.92 (5.7%)
Target 1 (1:1)	92.88 (+5.7%)
Target 2 (2:1)	97.86 (+11.3%)

ATR(14)	2.49 (2.8%)
Risk per Share	4.98
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	19.3	-1.23
Momentum	79.9	+1.20
Quality	64.1	+0.57
Composite	54.5

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 16.53 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	34.7	22.0	+58% above
P/B Ratio	12.7	4.0	Above

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

49.71

Market Price

87.90

Upside

-43.4%

Margin of Safety	-76.8%
Stage 1 PV (5yr FCF)	4,272,061,808
Terminal Value PV	14,486,327,377
Total Enterprise Value	18,758,389,185

Assumptions

Base FCF	763,778,188
Growth Rate (5yr)	13.1%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

51.12%

Full Kelly

25.56%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 79/100. Estimated win rate 64%, avg win 9.8%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

52.92

RSI(14)

2.209

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+15.9% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (10d since high)
Sector Outperformance	+12.9% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	52.92	NEUTRAL
Macd	2.209	BEARISH
Ma Cross	81.22 / 70.9	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.58x	NORMAL

Key Levels

Level	Price
52-Week High	92.59
Bollinger Upper	92.2
SMA(200)	70.9
SMA(50)	81.22
SMA(20)	89.89
Current Price	87.90
Bollinger Lower	87.58
52-Week Low	54.11
ATR(14)	2.49

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	0.74x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.53x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.47x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.41x	Normal bar — no special VSA pattern
2026-09-04	No Demand	0.58x	Low volume, narrow spread, weak close — no buying interest

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	89.93	Above Kijun
Kijun-sen (26)	86.05	Base line
Senkou A	87.99	Leading span A
Senkou B	79.94	Leading span B
Cloud	79.94 – 87.99	Bullish (Green)
Price vs Cloud	87.90	Inside Cloud
Chikou Span	83.45	Bullish
Alignment Score	3/4	NEUTRAL